Zacks Rating on Omnicell (OMCL)

Omnicell (OMCL) has an average broker rating of 1.33, which is interpreted as a Strong Buy, as rated by 6 equity analysts. Nonetheless, 5 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 1 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold.

Omnicell (OMCL) : The consensus price target for Omnicell (OMCL) is $40.6 for the short term with a standard deviation of $5.32. The most optimist securities analyst among the 5 who monitor the stock believes that the stock can reach $46, however, the pessimist price target for the company is $33.


Shares of Omnicell, Inc. rose by 0.7% in the last five trading days and 5.37% for the last 4 weeks. Omnicell, Inc. is up 18.68% in the last 3-month period. Year-to-Date the stock performance stands at 20.62%. Omnicell (NASDAQ:OMCL): stock turned positive on Tuesday. Though the stock opened at $37.21, the bulls momentum made the stock top out at $37.65 level for the day. The stock recorded a low of $37.04 and closed the trading day at $37.49, in the green by 0.78%. The total traded volume for the day was 83,361. The stock had closed at $37.2 in the previous days trading.

Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company has two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is organized around the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. The Companys products include OmniRx, SinglePointe, AnywhereRN, OptiFlex MS, OptiFlex CL, AccuFlex, Autobond, AutoGen, and SureSeal, among others.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.